(Q34320319)

1 August 2017

title

High readmission rates are associated with a significant economic burden and poor outcome in patients with grade III/IV acute GvHD. (English)

1 reference

1 August 2017

11

Claire E Dearden

1 reference

1 August 2017

Fiona L Dignan

1

1 reference

1 August 2017

Mike N Potter

2

1 reference

1 August 2017

Mark E Ethell

3

1 reference

1 August 2017

Matthew Taylor

4

1 reference

1 August 2017

Lily Lewis

5

1 reference

1 August 2017

Joy Brennan

6

1 reference

1 August 2017

Louise McNamara

7

1 reference

1 August 2017

Steve O Evans

8

1 reference

1 August 2017

Unell Riley

9

1 reference

1 August 2017

Faith E Davies

10

1 reference

1 August 2017

Gareth J Morgan

12

1 reference

1 August 2017

Bronwen E Shaw

13

1 reference

1 August 2017

publication date

28 December 2012

1 reference

1 August 2017

published in

Clinical Transplantation

1 reference

1 August 2017

volume

27

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

E56-63

1 reference

A prospective cost evaluation related to allogeneic haemopoietic stem cell transplantation including pretransplant procedures, transplantation and 1 year follow-up procedures

1 August 2017

cites work

1 reference

The costs and cost-effectiveness of allogeneic peripheral blood stem cell transplantation versus bone marrow transplantation in pediatric patients with acute leukemia

21 January 2018

1 reference

Increased costs after allogeneic haematopoietic SCT are associated with major complications and re-transplantation

21 January 2018

1 reference

Treatment costs and survival in patients with grades III-IV acute graft-versus-host disease after allogenic hematopoietic stem cell transplantation during three decades

21 January 2018

1 reference

Evaluation of readmissions in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

Evaluation of readmission in children receiving allogeneic hematopoietic stem cell transplantation: an institutional experience

21 January 2018

1 reference

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

21 January 2018

1 reference

How I treat refractory acute GVHD.

21 January 2018

1 reference

Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease

21 January 2018

1 reference

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report

21 January 2018

1 reference

Costs of pediatric allogeneic hematopoietic-cell transplantation

21 January 2018

1 reference

Parainfluenza type 3 infection post stem cell transplant: high prevalence but low mortality.

21 January 2018

1 reference

An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality

21 January 2018

1 reference

PREDICTING THE COSTS OF ALLOGENEIC SIBLING STEM-CELL TRANSPLANTATION: RESULTS FROM A PROSPECTIVE, MULTICENTER, FRENCH STUDY

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CTR.12065

1 reference

1 August 2017

1 reference